Biodesix (BDSX) Insider Trading & Ownership $0.45 -0.02 (-5.02%) Closing price 04:00 PM EasternExtended Trading$0.44 -0.01 (-1.21%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Biodesix (NASDAQ:BDSX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.10%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$393.50KNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$121.87K Get BDSX Insider Trade Alerts Want to know when executives and insiders are buying or selling Biodesix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BDSX Insider Buying and Selling by Quarter Biodesix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/13/2025Chris VazquezCAOSell228$0.42$95.76 8/13/2025Gary Anthony PestanoInsiderSell442$0.42$185.64 8/13/2025Kieran O'kaneInsiderSell476$0.42$199.92 8/13/2025Robin Harper CowieCFOSell988$0.42$414.96 8/13/2025Scott HuttonCEOSell3,772$0.42$1,584.24 5/12/2025Chris VazquezCAOSell112$0.36$40.32 5/12/2025Gary Anthony PestanoInsiderSell223$0.36$80.28 5/12/2025Robin Harper CowieCFOSell496$0.36$178.56 5/12/2025Scott HuttonCEOSell1,888$0.36$679.68 2/11/2025Chris VazquezCAOSell3,630$0.92$3,339.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/11/2025Gary Anthony PestanoInsiderSell16,748$0.92$15,408.16 2/11/2025Robin Harper CowieCFOSell24,664$0.92$22,690.88 2/11/2025Scott HuttonCEOSell83,660$0.92$76,967.20 11/20/2024Jack W SchulerDirectorBuy200,000$1.17$234,000.00 11/5/2024John PatienceChairmanBuy75,000$1.38$103,500.00 11/5/2024Matthew StrobeckDirectorBuy40,000$1.40$56,000.00 (Data available from 1/1/2013 forward) BDSX Insider Trading Activity - Frequently Asked Questions Who is on Biodesix's Insider Roster? The list of insiders at Biodesix includes Chris Vazquez, Gary Anthony Pestano, Hany Massarany, Jack W Schuler, John Patience, Kieran O'kane, Matthew Strobeck, Robin Harper Cowie, Ryan H Siurek, and Scott Hutton. Learn more on insiders at BDSX. What percentage of Biodesix stock is owned by insiders? 30.10% of Biodesix stock is owned by insiders. Learn more on BDSX's insider holdings. Which Biodesix insiders have been buying company stock? The following insiders have purchased BDSX shares in the last 24 months: Jack W Schuler ($234,000.00), John Patience ($103,500.00), and Matthew Strobeck ($56,000.00). How much insider buying is happening at Biodesix? Insiders have purchased a total of 315,000 BDSX shares in the last 24 months for a total of $393,500.00 bought. Which Biodesix insiders have been selling company stock? The following insiders have sold BDSX shares in the last 24 months: Chris Vazquez ($7,903.83), Gary Anthony Pestano ($36,869.82), Kieran O'kane ($199.92), Robin Harper Cowie ($60,850.70), and Scott Hutton ($209,058.21). How much insider selling is happening at Biodesix? Insiders have sold a total of 246,933 Biodesix shares in the last 24 months for a total of $314,882.48 sold. Biodesix Key ExecutivesMr. Scott Hutton (Age 52)President, CEO & Director Compensation: $614.92k2 recent tradesMs. Robin Harper Cowie (Age 44)CFO, Secretary & Treasurer Compensation: $390.3k2 recent tradesMr. Kieran O'Kane (Age 47)Chief Commercial Officer Compensation: $392.61kDr. Heinrich RöderFounder & CTOMr. Christopher VazquezVP, Controller & Chief Accounting OfficerMr. Mark DeBlockVice President of SalesMr. Robbie LuntSenior Director of MarketingMs. Jessica OlbrichtSenior Director of Human ResourcesDr. Gary Anthony Pestano Ph.D. (Age 57)Chief Development Officer Ms. Bobbi CoffinChief Growth Officer More Insider Trading Tools from MarketBeat Related Companies Exagen Insider Ownership DocGo Insider Ownership Quipt Home Medical Insider Ownership Sera Prognostics Insider Ownership P3 Health Partners Insider Ownership Marpai Insider Ownership Biorestorative Therapies Insider Ownership Mangoceuticals Insider Ownership SunLink Health Systems Insider Ownership Aclarion Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:BDSX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access